HuidaGene Therapeutics

Two healthcare providers looking at a computer screen
FDA clears application for CRISPR RNA-editing therapy developed using AI
By Jessica Hagen | 02:32 pm | November 04, 2024
The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.